Merck & Co., Inc.
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30250% above fair value
$149.52+3.19 (+2.18%)
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Pharmaceutical Segment by Year
Pharmaceutical Segment — Worldwide constant-currency (ex-exchange) growth YoY (%) (%)
Merck Pharmaceutical Segment: 1.0% in FY2025, down 9.0 pts from a year earlier. That is the lowest of the 8 years on record here.
Latest, FY2025
1.0%
Period ended Dec 31, 2025
Change on a year earlier
-9.0 pts
10.0% in FY2024
History
8 years
Since FY2017
Sources
8
Documents cited below
Where the FY2025 figure comes from
“|| PHARMACEUTICAL | 13,638 | 14,050 | 15,611 | 14,843 | 58,142 | 14,006 | 14,408 | 14,943 | 14,042 | 57,400 | 6 | 4 | 1 | 1”
Source: Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗
Reported in Form 8-K Table 3.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Pharmaceutical Segment — Worldwide constant-currency (ex-exchange) growth YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.0% | -9.0 pts | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| FY2024 | Dec 31, 2024 | 10.0% | +5.0 pts | Form 8-K (tm255059d1_ex99-1.htm, filed 2025-02-04) ↗ |
| FY2023 | Dec 31, 2023 | 5.0% | – | Form 8-K (tm244517d1_ex99-1.htm, filed 2024-02-01) ↗ |
| FY2021 | Dec 31, 2021 | 15.0% | +11.0 pts | Form 8-K (tm222755d1_ex99-1.htm, filed 2022-02-03) ↗ |
| FY2020 | Dec 31, 2020 | 4.0% | -10.0 pts | Form 8-K (tm213179d2_ex99-1.htm, filed 2021-02-04) ↗ |
| FY2019 | Dec 31, 2019 | 14.0% | +8.0 pts | Form 8-K (tm206551d1_ex99-1.htm, filed 2020-02-05) ↗ |
| FY2018 | Dec 31, 2018 | 6.0% | +5.0 pts | Form 8-K (a19-3795_1ex99d1.htm, filed 2019-02-01) ↗ |
| FY2017 | Dec 31, 2017 | 1.0% | – | Form 8-K (a18-5152_1ex99d1.htm, filed 2018-02-02) ↗ |
Cite this data
StockData. (2026). Merck Pharmaceutical Segment (%), annual FY2017–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev-pharma-ww-exfx-yoy
See every metric in the Merck KPI table. Data updated Oct 26, 2026.